Rank | Gene Set | Z-score |
---|---|---|
1 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 6.73457797 |
2 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 6.63918630 |
3 | actin nucleation (GO:0045010) | 5.87411166 |
4 | cytidine metabolic process (GO:0046087) | 5.44885584 |
5 | cytidine catabolic process (GO:0006216) | 5.44885584 |
6 | cytidine deamination (GO:0009972) | 5.44885584 |
7 | DNA deamination (GO:0045006) | 5.40817534 |
8 | sequestering of actin monomers (GO:0042989) | 5.14915994 |
9 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.96980808 |
10 | gonadal mesoderm development (GO:0007506) | 4.76900381 |
11 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.74117996 |
12 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 4.65210667 |
13 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 4.64126078 |
14 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 4.42781196 |
15 | cytolysis (GO:0019835) | 4.27913766 |
16 | deoxyribose phosphate biosynthetic process (GO:0046385) | 4.27574630 |
17 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 4.27574630 |
18 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 4.26685923 |
19 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.25914641 |
20 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.22663102 |
21 | negative regulation by host of viral transcription (GO:0043922) | 4.17918153 |
22 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.99631114 |
23 | negative regulation of stress fiber assembly (GO:0051497) | 3.93840573 |
24 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.92966404 |
25 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.92724330 |
26 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.88601633 |
27 | ATP synthesis coupled proton transport (GO:0015986) | 3.88601633 |
28 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.88505990 |
29 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.87431030 |
30 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.87431030 |
31 | negative regulation of ligase activity (GO:0051352) | 3.87328235 |
32 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.87328235 |
33 | protein maturation by protein folding (GO:0022417) | 3.85140865 |
34 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.84718429 |
35 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.84718429 |
36 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.84718429 |
37 | respiratory electron transport chain (GO:0022904) | 3.81350137 |
38 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.75034096 |
39 | electron transport chain (GO:0022900) | 3.73618392 |
40 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.69849646 |
41 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.69849646 |
42 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.68399853 |
43 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.68399853 |
44 | positive regulation of lamellipodium assembly (GO:0010592) | 3.67803771 |
45 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.67264838 |
46 | macrophage chemotaxis (GO:0048246) | 3.67203707 |
47 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.67180819 |
48 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.62854424 |
49 | deoxyribonucleotide biosynthetic process (GO:0009263) | 3.60284016 |
50 | piRNA metabolic process (GO:0034587) | 3.58195797 |
51 | negative regulation of T cell differentiation in thymus (GO:0033085) | 3.53232558 |
52 | histone H2A acetylation (GO:0043968) | 3.52263816 |
53 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.42702675 |
54 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 3.38429171 |
55 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.38197554 |
56 | deoxyribonucleoside diphosphate metabolic process (GO:0009186) | 3.36852996 |
57 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.28915209 |
58 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.23277105 |
59 | ubiquinone biosynthetic process (GO:0006744) | 3.23057363 |
60 | positive thymic T cell selection (GO:0045059) | 3.22346117 |
61 | positive regulation of T cell apoptotic process (GO:0070234) | 3.19272471 |
62 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.16616832 |
63 | DNA ligation (GO:0006266) | 3.14855603 |
64 | negative regulation of oxidoreductase activity (GO:0051354) | 3.14673486 |
65 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.14451987 |
66 | positive regulation of ligase activity (GO:0051351) | 3.13639926 |
67 | positive regulation of cell cycle arrest (GO:0071158) | 3.12132803 |
68 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 3.07543236 |
69 | CENP-A containing nucleosome assembly (GO:0034080) | 3.06882210 |
70 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.04979766 |
71 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.04960262 |
72 | negative regulation of cell fate specification (GO:0009996) | 3.02839466 |
73 | ubiquinone metabolic process (GO:0006743) | 3.02548681 |
74 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 3.00492541 |
75 | iron-sulfur cluster assembly (GO:0016226) | 2.99327845 |
76 | metallo-sulfur cluster assembly (GO:0031163) | 2.99327845 |
77 | positive regulation of lamellipodium organization (GO:1902745) | 2.97522795 |
78 | regulation of cellular amine metabolic process (GO:0033238) | 2.97298097 |
79 | execution phase of apoptosis (GO:0097194) | 2.97017411 |
80 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.96758800 |
81 | negative regulation of actin filament bundle assembly (GO:0032232) | 2.95875029 |
82 | mechanosensory behavior (GO:0007638) | 2.95424157 |
83 | mismatch repair (GO:0006298) | 2.95193834 |
84 | chromatin remodeling at centromere (GO:0031055) | 2.94793015 |
85 | auditory receptor cell differentiation (GO:0042491) | 2.94596615 |
86 | deoxyribose phosphate metabolic process (GO:0019692) | 2.94069173 |
87 | viral mRNA export from host cell nucleus (GO:0046784) | 2.92770858 |
88 | protein deneddylation (GO:0000338) | 2.90042341 |
89 | positive regulation of translational initiation (GO:0045948) | 2.86209531 |
90 | deoxyribonucleotide catabolic process (GO:0009264) | 2.85665924 |
91 | protein localization to kinetochore (GO:0034501) | 2.84996345 |
92 | purine deoxyribonucleotide metabolic process (GO:0009151) | 2.82636603 |
93 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.82568049 |
94 | platelet dense granule organization (GO:0060155) | 2.82021505 |
95 | negative regulation of monooxygenase activity (GO:0032769) | 2.81898293 |
96 | deoxyribose phosphate catabolic process (GO:0046386) | 2.79363254 |
97 | positive regulation of protein homodimerization activity (GO:0090073) | 2.79307094 |
98 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.79082439 |
99 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.78732194 |
100 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.78048322 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.01133211 |
2 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 4.94272158 |
3 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 4.29258579 |
4 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.15747345 |
5 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.54587978 |
6 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.40824837 |
7 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.38945942 |
8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.10063921 |
9 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.94197231 |
10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.89305073 |
11 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.57647706 |
12 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.55975986 |
13 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.51922510 |
14 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.45971295 |
15 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.39379918 |
16 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.38152845 |
17 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.37459710 |
18 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.34774062 |
19 | VDR_22108803_ChIP-Seq_LS180_Human | 2.22450705 |
20 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.17433329 |
21 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.12762607 |
22 | MYB_26560356_Chip-Seq_TH2_Human | 2.11694177 |
23 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.10780751 |
24 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.10757643 |
25 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.10445145 |
26 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.09425325 |
27 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.95882235 |
28 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.92320688 |
29 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.91421899 |
30 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.89963114 |
31 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.86856269 |
32 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.78533195 |
33 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.75202694 |
34 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.74584048 |
35 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.67756258 |
36 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67208894 |
37 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.61053725 |
38 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.57781182 |
39 | GATA3_26560356_Chip-Seq_TH2_Human | 1.52233577 |
40 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.45330140 |
41 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.43690618 |
42 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43396190 |
43 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.42766231 |
44 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.41908847 |
45 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.41017536 |
46 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.36439614 |
47 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.31622394 |
48 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.28545748 |
49 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.27075939 |
50 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.26308675 |
51 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.26111759 |
52 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.25645984 |
53 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.21110362 |
54 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.18328852 |
55 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.17578017 |
56 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.16196450 |
57 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.13904598 |
58 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.13286569 |
59 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.12460312 |
60 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.12176020 |
61 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.08968691 |
62 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07524798 |
63 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.07073683 |
64 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.06862130 |
65 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.05781564 |
66 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.05298612 |
67 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.04939153 |
68 | AR_20517297_ChIP-Seq_VCAP_Human | 1.04067590 |
69 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.03955629 |
70 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.02438883 |
71 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.01095388 |
72 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.00581116 |
73 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.98782091 |
74 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.97536674 |
75 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.96899093 |
76 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.96112754 |
77 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.95500202 |
78 | P300_27268052_Chip-Seq_Bcells_Human | 0.94294227 |
79 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.94065009 |
80 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.93823785 |
81 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.93817598 |
82 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.92498524 |
83 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.91683415 |
84 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.91626560 |
85 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.90683694 |
86 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.90282282 |
87 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.90282282 |
88 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.89381561 |
89 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89221041 |
90 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.88213534 |
91 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.87996700 |
92 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.87971012 |
93 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.87960838 |
94 | NCOR_22424771_ChIP-Seq_293T_Human | 0.86289883 |
95 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.86010376 |
96 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.85481833 |
97 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.85481833 |
98 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.85103370 |
99 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.85017476 |
100 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.84623316 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005451_abnormal_body_composition | 5.49686172 |
2 | MP0005671_abnormal_response_to | 4.84310622 |
3 | MP0004147_increased_porphyrin_level | 4.33900564 |
4 | MP0003763_abnormal_thymus_physiology | 3.47932686 |
5 | MP0001485_abnormal_pinna_reflex | 2.48602454 |
6 | MP0002166_altered_tumor_susceptibility | 2.45940731 |
7 | MP0009333_abnormal_splenocyte_physiolog | 2.35082381 |
8 | MP0005645_abnormal_hypothalamus_physiol | 2.21151706 |
9 | MP0001873_stomach_inflammation | 2.18790579 |
10 | MP0001835_abnormal_antigen_presentation | 2.05711665 |
11 | MP0009785_altered_susceptibility_to | 2.04611263 |
12 | MP0003693_abnormal_embryo_hatching | 2.00264626 |
13 | MP0001905_abnormal_dopamine_level | 1.93656616 |
14 | MP0003806_abnormal_nucleotide_metabolis | 1.87574778 |
15 | MP0003183_abnormal_peptide_metabolism | 1.86115744 |
16 | MP0002933_joint_inflammation | 1.82621308 |
17 | MP0002006_tumorigenesis | 1.81804639 |
18 | MP0001800_abnormal_humoral_immune | 1.76946501 |
19 | MP0003283_abnormal_digestive_organ | 1.76467131 |
20 | MP0005084_abnormal_gallbladder_morpholo | 1.67220816 |
21 | MP0008877_abnormal_DNA_methylation | 1.65923975 |
22 | MP0003878_abnormal_ear_physiology | 1.65429452 |
23 | MP0005377_hearing/vestibular/ear_phenot | 1.65429452 |
24 | MP0010094_abnormal_chromosome_stability | 1.62256111 |
25 | MP0005551_abnormal_eye_electrophysiolog | 1.59735050 |
26 | MP0010386_abnormal_urinary_bladder | 1.56098087 |
27 | MP0005000_abnormal_immune_tolerance | 1.53557711 |
28 | MP0004145_abnormal_muscle_electrophysio | 1.49576807 |
29 | MP0002420_abnormal_adaptive_immunity | 1.49044842 |
30 | MP0006292_abnormal_olfactory_placode | 1.44248795 |
31 | MP0001790_abnormal_immune_system | 1.43811493 |
32 | MP0005387_immune_system_phenotype | 1.43811493 |
33 | MP0002723_abnormal_immune_serum | 1.41166730 |
34 | MP0002138_abnormal_hepatobiliary_system | 1.40375609 |
35 | MP0001819_abnormal_immune_cell | 1.39531838 |
36 | MP0005025_abnormal_response_to | 1.37852650 |
37 | MP0002102_abnormal_ear_morphology | 1.37275756 |
38 | MP0008789_abnormal_olfactory_epithelium | 1.36492780 |
39 | MP0003786_premature_aging | 1.35972805 |
40 | MP0002837_dystrophic_cardiac_calcinosis | 1.35528300 |
41 | MP0003195_calcinosis | 1.35297620 |
42 | MP0006082_CNS_inflammation | 1.34727520 |
43 | MP0002160_abnormal_reproductive_system | 1.31495902 |
44 | MP0005389_reproductive_system_phenotype | 1.30291334 |
45 | MP0005646_abnormal_pituitary_gland | 1.28007801 |
46 | MP0003011_delayed_dark_adaptation | 1.27635475 |
47 | MP0003866_abnormal_defecation | 1.26943140 |
48 | MP0002452_abnormal_antigen_presenting | 1.26715840 |
49 | MP0006072_abnormal_retinal_apoptosis | 1.26578522 |
50 | MP0006036_abnormal_mitochondrial_physio | 1.25365518 |
51 | MP0002876_abnormal_thyroid_physiology | 1.23946082 |
52 | MP0002234_abnormal_pharynx_morphology | 1.23448089 |
53 | MP0003718_maternal_effect | 1.22986967 |
54 | MP0008875_abnormal_xenobiotic_pharmacok | 1.22939299 |
55 | MP0001542_abnormal_bone_strength | 1.22775207 |
56 | MP0001968_abnormal_touch/_nociception | 1.22257852 |
57 | MP0008872_abnormal_physiological_respon | 1.21899201 |
58 | MP0004957_abnormal_blastocyst_morpholog | 1.18663342 |
59 | MP0001845_abnormal_inflammatory_respons | 1.16705401 |
60 | MP0002398_abnormal_bone_marrow | 1.16197625 |
61 | MP0002638_abnormal_pupillary_reflex | 1.13954793 |
62 | MP0000685_abnormal_immune_system | 1.13851965 |
63 | MP0002148_abnormal_hypersensitivity_rea | 1.12677408 |
64 | MP0000716_abnormal_immune_system | 1.09735451 |
65 | MP0000703_abnormal_thymus_morphology | 1.08076432 |
66 | MP0000689_abnormal_spleen_morphology | 1.04428730 |
67 | MP0008932_abnormal_embryonic_tissue | 1.03203371 |
68 | MP0001764_abnormal_homeostasis | 1.01162861 |
69 | MP0003111_abnormal_nucleus_morphology | 1.00703276 |
70 | MP0002822_catalepsy | 1.00084405 |
71 | MP0004742_abnormal_vestibular_system | 0.99676329 |
72 | MP0005647_abnormal_sex_gland | 0.97753739 |
73 | MP0001919_abnormal_reproductive_system | 0.97112988 |
74 | MP0003252_abnormal_bile_duct | 0.95148434 |
75 | MP0004142_abnormal_muscle_tone | 0.94425625 |
76 | MP0001986_abnormal_taste_sensitivity | 0.92315927 |
77 | MP0002736_abnormal_nociception_after | 0.90874378 |
78 | MP0005394_taste/olfaction_phenotype | 0.89613052 |
79 | MP0005499_abnormal_olfactory_system | 0.89613052 |
80 | MP0002722_abnormal_immune_system | 0.89134596 |
81 | MP0001666_abnormal_nutrient_absorption | 0.87287078 |
82 | MP0000681_abnormal_thyroid_gland | 0.85796116 |
83 | MP0002405_respiratory_system_inflammati | 0.85122945 |
84 | MP0002429_abnormal_blood_cell | 0.83679317 |
85 | MP0008007_abnormal_cellular_replicative | 0.78941079 |
86 | MP0000372_irregular_coat_pigmentation | 0.77032124 |
87 | MP0003448_altered_tumor_morphology | 0.76125269 |
88 | MP0001486_abnormal_startle_reflex | 0.74708886 |
89 | MP0005636_abnormal_mineral_homeostasis | 0.74562903 |
90 | MP0001188_hyperpigmentation | 0.74279407 |
91 | MP0002019_abnormal_tumor_incidence | 0.73801766 |
92 | MP0005395_other_phenotype | 0.73654039 |
93 | MP0002653_abnormal_ependyma_morphology | 0.72538742 |
94 | MP0001929_abnormal_gametogenesis | 0.71112843 |
95 | MP0010155_abnormal_intestine_physiology | 0.70902157 |
96 | MP0002693_abnormal_pancreas_physiology | 0.70758766 |
97 | MP0001119_abnormal_female_reproductive | 0.70727417 |
98 | MP0000639_abnormal_adrenal_gland | 0.69705477 |
99 | MP0008260_abnormal_autophagy | 0.69578631 |
100 | MP0005253_abnormal_eye_physiology | 0.67983945 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of B cell number (HP:0010975) | 6.29138370 |
2 | B lymphocytopenia (HP:0010976) | 6.23216763 |
3 | Increased IgM level (HP:0003496) | 5.47934619 |
4 | Aplastic anemia (HP:0001915) | 4.93637621 |
5 | IgG deficiency (HP:0004315) | 4.48135580 |
6 | T lymphocytopenia (HP:0005403) | 4.44406019 |
7 | Abnormality of T cell number (HP:0011839) | 4.22241162 |
8 | Severe combined immunodeficiency (HP:0004430) | 3.99462099 |
9 | Combined immunodeficiency (HP:0005387) | 3.65487206 |
10 | Abnormality of the prostate (HP:0008775) | 3.61823273 |
11 | Hypoproteinemia (HP:0003075) | 3.54460025 |
12 | Pancytopenia (HP:0001876) | 3.48555519 |
13 | Abolished electroretinogram (ERG) (HP:0000550) | 3.43714117 |
14 | Autoimmune hemolytic anemia (HP:0001890) | 3.41552905 |
15 | Decreased central vision (HP:0007663) | 3.39683070 |
16 | Attenuation of retinal blood vessels (HP:0007843) | 3.34138909 |
17 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.05201219 |
18 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.00246769 |
19 | Mitochondrial inheritance (HP:0001427) | 2.94276173 |
20 | Chromsome breakage (HP:0040012) | 2.93291773 |
21 | Pendular nystagmus (HP:0012043) | 2.88452776 |
22 | Thyroiditis (HP:0100646) | 2.85062287 |
23 | Abnormality of T cells (HP:0002843) | 2.74856032 |
24 | Increased hepatocellular lipid droplets (HP:0006565) | 2.73840264 |
25 | Gastrointestinal infarctions (HP:0005244) | 2.70834971 |
26 | Encephalitis (HP:0002383) | 2.69250366 |
27 | Lymphopenia (HP:0001888) | 2.68433250 |
28 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.63971925 |
29 | Increased corneal curvature (HP:0100692) | 2.63694692 |
30 | Keratoconus (HP:0000563) | 2.63694692 |
31 | Acute necrotizing encephalopathy (HP:0006965) | 2.63045864 |
32 | Cerebral palsy (HP:0100021) | 2.62646925 |
33 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.60498201 |
34 | Hypoplasia of the thymus (HP:0000778) | 2.59050709 |
35 | IgM deficiency (HP:0002850) | 2.56230280 |
36 | Increased intramyocellular lipid droplets (HP:0012240) | 2.55435181 |
37 | Recurrent bronchitis (HP:0002837) | 2.53667276 |
38 | Abnormality of binocular vision (HP:0011514) | 2.52210710 |
39 | Diplopia (HP:0000651) | 2.52210710 |
40 | Renal Fanconi syndrome (HP:0001994) | 2.50101969 |
41 | Chronic diarrhea (HP:0002028) | 2.47962570 |
42 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.45370849 |
43 | Ureteral stenosis (HP:0000071) | 2.41176937 |
44 | Cellular immunodeficiency (HP:0005374) | 2.38356040 |
45 | Chronic obstructive pulmonary disease (HP:0006510) | 2.37729477 |
46 | Obstructive lung disease (HP:0006536) | 2.37729477 |
47 | 3-Methylglutaconic aciduria (HP:0003535) | 2.34579762 |
48 | Increased CSF lactate (HP:0002490) | 2.33918531 |
49 | Colon cancer (HP:0003003) | 2.32595532 |
50 | Autoimmune thrombocytopenia (HP:0001973) | 2.32428904 |
51 | Amyotrophic lateral sclerosis (HP:0007354) | 2.31323815 |
52 | Generalized aminoaciduria (HP:0002909) | 2.29671737 |
53 | Hepatic necrosis (HP:0002605) | 2.29192881 |
54 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.25696033 |
55 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.25696033 |
56 | Abnormality of the renal collecting system (HP:0004742) | 2.25125773 |
57 | Lipid accumulation in hepatocytes (HP:0006561) | 2.23131024 |
58 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.21004947 |
59 | Pancreatic fibrosis (HP:0100732) | 2.19130600 |
60 | Reticulocytopenia (HP:0001896) | 2.16046935 |
61 | Oral leukoplakia (HP:0002745) | 2.15610484 |
62 | Hepatocellular necrosis (HP:0001404) | 2.15443249 |
63 | Amaurosis fugax (HP:0100576) | 2.11415250 |
64 | Ureteral obstruction (HP:0006000) | 2.10732916 |
65 | Lymphoma (HP:0002665) | 2.09436397 |
66 | Duplicated collecting system (HP:0000081) | 2.07021805 |
67 | Meningitis (HP:0001287) | 2.05420004 |
68 | Mediastinal lymphadenopathy (HP:0100721) | 2.05288449 |
69 | Progressive macrocephaly (HP:0004481) | 2.04402881 |
70 | Optic disc pallor (HP:0000543) | 2.03102451 |
71 | Acute hepatic failure (HP:0006554) | 2.01637529 |
72 | Joint swelling (HP:0001386) | 2.01540133 |
73 | Macular degeneration (HP:0000608) | 2.01523937 |
74 | Abnormality of eosinophils (HP:0001879) | 1.99444495 |
75 | Abnormality of male internal genitalia (HP:0000022) | 1.98922673 |
76 | Dicarboxylic aciduria (HP:0003215) | 1.97316309 |
77 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.97316309 |
78 | Increased muscle lipid content (HP:0009058) | 1.96862078 |
79 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.96133109 |
80 | Acute encephalopathy (HP:0006846) | 1.96092669 |
81 | Hypergammaglobulinemia (HP:0010702) | 1.92149175 |
82 | Gonadotropin excess (HP:0000837) | 1.87951212 |
83 | Exertional dyspnea (HP:0002875) | 1.87764936 |
84 | Vertebral compression fractures (HP:0002953) | 1.86192015 |
85 | Chest pain (HP:0100749) | 1.86124441 |
86 | Recurrent sinusitis (HP:0011108) | 1.85779980 |
87 | Neoplasm of the adrenal gland (HP:0100631) | 1.80978087 |
88 | Horseshoe kidney (HP:0000085) | 1.80567073 |
89 | Periorbital edema (HP:0100539) | 1.79591370 |
90 | Absent thumb (HP:0009777) | 1.79537301 |
91 | Gout (HP:0001997) | 1.75955961 |
92 | Premature graying of hair (HP:0002216) | 1.74062743 |
93 | Increased serum lactate (HP:0002151) | 1.73462184 |
94 | Bronchitis (HP:0012387) | 1.73170260 |
95 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.72911636 |
96 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 1.72775700 |
97 | Neutropenia (HP:0001875) | 1.72219306 |
98 | Abnormality of midbrain morphology (HP:0002418) | 1.71753767 |
99 | Molar tooth sign on MRI (HP:0002419) | 1.71753767 |
100 | Pigmentary retinal degeneration (HP:0001146) | 1.71500050 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TESK2 | 6.69685896 |
2 | KDR | 5.99072317 |
3 | VRK2 | 3.56039601 |
4 | TESK1 | 3.32148004 |
5 | LIMK1 | 3.08452733 |
6 | MAP3K12 | 2.88139832 |
7 | TXK | 2.79990217 |
8 | BUB1 | 2.73996371 |
9 | MAP4K1 | 2.32314503 |
10 | PLK4 | 2.29927396 |
11 | NUAK1 | 2.13962402 |
12 | MAP3K11 | 1.93717409 |
13 | VRK1 | 1.93298352 |
14 | BRSK2 | 1.88498388 |
15 | ADRBK2 | 1.68991870 |
16 | MAP4K2 | 1.68501744 |
17 | TAOK3 | 1.59026408 |
18 | ITK | 1.57655743 |
19 | NEK1 | 1.27847380 |
20 | TAF1 | 1.27341306 |
21 | BCKDK | 1.23112870 |
22 | BRSK1 | 1.22875017 |
23 | GRK5 | 1.22135115 |
24 | GRK1 | 1.19547365 |
25 | BLK | 1.16242759 |
26 | MST4 | 1.07616826 |
27 | CDC7 | 1.04511533 |
28 | TEC | 1.00946297 |
29 | GRK7 | 0.98902447 |
30 | CDK8 | 0.95550754 |
31 | WNK4 | 0.94730469 |
32 | NME1 | 0.94518251 |
33 | DAPK1 | 0.90324382 |
34 | ZAK | 0.89686718 |
35 | PLK3 | 0.86911420 |
36 | ZAP70 | 0.85658426 |
37 | CSNK1G3 | 0.84815516 |
38 | SYK | 0.84651771 |
39 | DYRK2 | 0.83917013 |
40 | CAMKK2 | 0.83563300 |
41 | CSF1R | 0.82452801 |
42 | MYLK | 0.80095456 |
43 | MELK | 0.77451136 |
44 | BMPR1B | 0.75101138 |
45 | EIF2AK1 | 0.73234082 |
46 | FRK | 0.72651030 |
47 | AURKA | 0.71424566 |
48 | DYRK1B | 0.71171927 |
49 | CDK9 | 0.69803328 |
50 | LATS1 | 0.69669366 |
51 | CSK | 0.68759740 |
52 | PLK1 | 0.65799499 |
53 | CSNK1G1 | 0.64860715 |
54 | BTK | 0.63855228 |
55 | WEE1 | 0.63215926 |
56 | AURKB | 0.61177321 |
57 | LRRK2 | 0.61160654 |
58 | PRKD3 | 0.60173086 |
59 | FES | 0.59942956 |
60 | STK16 | 0.58268535 |
61 | CSNK1A1L | 0.57121520 |
62 | LYN | 0.55421839 |
63 | INSRR | 0.55053052 |
64 | CDK7 | 0.54470456 |
65 | LCK | 0.53977723 |
66 | ATR | 0.52607742 |
67 | PRKCQ | 0.52510975 |
68 | CDK11A | 0.51737770 |
69 | MAP3K5 | 0.49755271 |
70 | CDK14 | 0.47622561 |
71 | RPS6KA5 | 0.47303915 |
72 | CDK18 | 0.46655292 |
73 | CDK15 | 0.46502513 |
74 | BCR | 0.46235004 |
75 | CSNK1G2 | 0.44798651 |
76 | WNK3 | 0.44203462 |
77 | RPS6KA4 | 0.42797132 |
78 | CSNK2A1 | 0.42021106 |
79 | TNK2 | 0.41900924 |
80 | TYRO3 | 0.41253121 |
81 | EIF2AK3 | 0.41240994 |
82 | ROCK1 | 0.40820135 |
83 | PAK1 | 0.39367408 |
84 | TIE1 | 0.39258542 |
85 | MAPKAPK2 | 0.38003359 |
86 | EIF2AK2 | 0.37613043 |
87 | CLK1 | 0.37024558 |
88 | PLK2 | 0.36019089 |
89 | TBK1 | 0.35453219 |
90 | DAPK3 | 0.32098930 |
91 | SRPK1 | 0.32057996 |
92 | PIM2 | 0.31815455 |
93 | PKN1 | 0.31687478 |
94 | ERBB3 | 0.29669937 |
95 | MAPK13 | 0.29590175 |
96 | DYRK1A | 0.29282166 |
97 | TLK1 | 0.28823635 |
98 | PRKCA | 0.27389428 |
99 | NTRK2 | 0.27220102 |
100 | WNK1 | 0.27139082 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Proteasome_Homo sapiens_hsa03050 | 5.40760621 |
2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.53549780 |
3 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.52411343 |
4 | Parkinsons disease_Homo sapiens_hsa05012 | 3.39960383 |
5 | DNA replication_Homo sapiens_hsa03030 | 2.75437963 |
6 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.48221093 |
7 | Mismatch repair_Homo sapiens_hsa03430 | 2.38696509 |
8 | Protein export_Homo sapiens_hsa03060 | 2.29400616 |
9 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.27958141 |
10 | RNA polymerase_Homo sapiens_hsa03020 | 2.26983294 |
11 | Alzheimers disease_Homo sapiens_hsa05010 | 2.24750008 |
12 | Huntingtons disease_Homo sapiens_hsa05016 | 2.14137342 |
13 | Homologous recombination_Homo sapiens_hsa03440 | 2.07504485 |
14 | Ribosome_Homo sapiens_hsa03010 | 2.01026681 |
15 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.86476445 |
16 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.80091120 |
17 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.74896804 |
18 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.72717814 |
19 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.65571928 |
20 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.65128977 |
21 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.62092288 |
22 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.48730966 |
23 | Allograft rejection_Homo sapiens_hsa05330 | 1.48596771 |
24 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.47327991 |
25 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.45367962 |
26 | Base excision repair_Homo sapiens_hsa03410 | 1.43579041 |
27 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.38368280 |
28 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.33183723 |
29 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.32131177 |
30 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.31906518 |
31 | Shigellosis_Homo sapiens_hsa05131 | 1.28213829 |
32 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.28076646 |
33 | RNA degradation_Homo sapiens_hsa03018 | 1.27629943 |
34 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.25387991 |
35 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.24998185 |
36 | Phototransduction_Homo sapiens_hsa04744 | 1.23688046 |
37 | Purine metabolism_Homo sapiens_hsa00230 | 1.23212013 |
38 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.15875070 |
39 | Asthma_Homo sapiens_hsa05310 | 1.13620366 |
40 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.02258489 |
41 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.98806079 |
42 | Viral myocarditis_Homo sapiens_hsa05416 | 0.96643906 |
43 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.96481991 |
44 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.93662912 |
45 | Salmonella infection_Homo sapiens_hsa05132 | 0.91830902 |
46 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.88419157 |
47 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.87286788 |
48 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.86857798 |
49 | RNA transport_Homo sapiens_hsa03013 | 0.82889700 |
50 | Spliceosome_Homo sapiens_hsa03040 | 0.82687300 |
51 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.74559084 |
52 | Measles_Homo sapiens_hsa05162 | 0.74540433 |
53 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.74122196 |
54 | Basal transcription factors_Homo sapiens_hsa03022 | 0.69113924 |
55 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.64623545 |
56 | Cell cycle_Homo sapiens_hsa04110 | 0.64262796 |
57 | Peroxisome_Homo sapiens_hsa04146 | 0.63816600 |
58 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.63812038 |
59 | Olfactory transduction_Homo sapiens_hsa04740 | 0.60540344 |
60 | Taste transduction_Homo sapiens_hsa04742 | 0.58045176 |
61 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.57049528 |
62 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.57045358 |
63 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.55584707 |
64 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.53159713 |
65 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.52558544 |
66 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.51903212 |
67 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.51899602 |
68 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.50682230 |
69 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.50514812 |
70 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.48822008 |
71 | Metabolic pathways_Homo sapiens_hsa01100 | 0.48110519 |
72 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.45847618 |
73 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.45746150 |
74 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.45296090 |
75 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.42972302 |
76 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.38763366 |
77 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.38284454 |
78 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.36965936 |
79 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.36778965 |
80 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.36599707 |
81 | Prion diseases_Homo sapiens_hsa05020 | 0.36593768 |
82 | Retinol metabolism_Homo sapiens_hsa00830 | 0.35272422 |
83 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.32193269 |
84 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.29997892 |
85 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.29798354 |
86 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.29513064 |
87 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.29205619 |
88 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.28033033 |
89 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.27890707 |
90 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.26890560 |
91 | Legionellosis_Homo sapiens_hsa05134 | 0.26613416 |
92 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.26159057 |
93 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.24287140 |
94 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.23484545 |
95 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.22392550 |
96 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.21801836 |
97 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.21179002 |
98 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.21008053 |
99 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.20808358 |
100 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.19749177 |